Medication Reconciliation in Home Health: Running the Drug Regimen Review at the Kitchen Table

The hospital discharge summary lists six medications. On the kitchen counter there are eleven bottles, a pill organizer filled by a neighbor, and a blood pressure tablet the patient was told to stop but still takes "when I feel it." The nurse has 40 minutes left in the visit and a start of care OASIS to finish.

Medication reconciliation in home health is the part of the comprehensive assessment where the referral meets reality. It is also one of the most specific sets of requirements in the home health record: a regulation that names what the review must look for, OASIS items with a hard clock, and a follow-up item reported again at transfer and discharge. This guide sets out what is required for home health and hospice, how the next-day midnight rule works, and a method nurses can run at the kitchen table.

What the Regulations Require

For home health, 42 CFR 484.55(c)(5) requires the comprehensive assessment to include a review of all medications the patient is currently using, in order to identify potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy and noncompliance with drug therapy. Under 484.55(b), the comprehensive assessment must be completed no later than 5 calendar days after the start of care.

For hospice, 42 CFR 418.54(c)(6) requires a drug profile: a review of all prescription and over-the-counter drugs, herbal remedies and other alternative treatments that could affect drug therapy. It names five things to identify: effectiveness of drug therapy, drug side effects, actual or potential interactions, duplicate drug therapy, and drug therapy currently associated with laboratory monitoring. The hospice comprehensive assessment is due within 5 calendar days after the election, and under 418.54(d) it must be updated at least every 15 days.

Note the hospice list includes laboratory monitoring and the home health list includes noncompliance. Agencies running both lines on one template tend to drop one of them.

How OASIS-E2 Defines the Drug Regimen Review

The OASIS-E2 Guidance Manual, effective April 1, 2026, defines the drug regimen review in post-acute care as generally including medication reconciliation, a review of all medications the patient is currently using, and a review of the drug regimen to identify, and if possible prevent, potential clinically significant medication issues.

The scope is wider than most referral lists. The manual says the review includes all medications, prescribed and over the counter, including nutritional supplements, vitamins and homeopathic and herbal products, by any route, and also total parenteral nutrition and oxygen.

Four items carry the result:

• M2001 Drug Regimen Review (start and resumption of care): was a review done, and were potential or actual clinically significant issues found?
• M2003 Medication Follow-up (start and resumption of care): were those issues communicated to the physician or allowed practitioner, with prescribed or recommended actions completed, by midnight of the next calendar day?
• M2005 Medication Intervention (transfer, death at home and discharge): the same question, looking back across the whole quality episode since the most recent start or resumption of care.
• M2010 Patient/Caregiver High-Risk Drug Education (start and resumption of care): was the patient or caregiver instructed about all high-risk medications?

N0415, High-Risk Drug Classes: Use and Indication, sits beside them and asks whether the patient takes drugs in specific classes and whether a patient-specific indication is documented. The OASIS-E2 changes post covers the items producing the most rework since April.

The Midnight Rule, Precisely

The manual defines a clinically significant medication issue as one that, in the clinician's professional judgment, warrants physician or allowed practitioner communication and completion of prescribed or recommended actions by midnight of the next calendar day at the latest. Anything that does not need that level of attention is not a clinically significant issue for these items.

Three details decide how M2003 gets coded:

1. 1.The clock runs from identification. An issue found at 10:00 AM on February 12 must be resolved by 11:59 PM on February 13. So must an issue found at 10:00 PM on February 12. A late-evening discovery gets the shortest real window.
2. 2.Two-way communication is required. A voicemail left at the practitioner's office does not stop the clock. The manual's examples code M2003 as 0, No when the clinician reported the issue in time but the practitioner's response came after midnight of the next day.
3. 3.Actions that take longer still count if started. If the practitioner orders monitoring over the next three days, M2003 can be coded 1, Yes as long as the agency took whatever actions were possible by the deadline.

The manual also says that if any element of the review is skipped, for example drug interactions were not checked, the review is incomplete and M2001 is reported with a dash. CMS expects dashes to be rare.

A Kitchen-Table Method

The review works best as a fixed sequence, the same at every start and resumption of care, so nothing depends on memory.

1. 1.Gather every source before comparing. Discharge medication list, referral orders, pharmacy labels, the pill organizer, and what the patient and family say they actually take. The OASIS manual lists facility records, the most recent history and physical, transfer documents, discharge summaries and medication lists as data sources for N0415, and discussions with the hospital, clinicians and family to clarify them.
2. 2.Lay out the bottles. Ask the patient to bring every medication, including the bathroom cabinet, the purse and the car. Ask specifically about vitamins, supplements, herbal products, eye drops, inhalers, patches and oxygen.
3. 3.Build one list. For each item: name, strength, dose, route, frequency, prescriber, pharmacy, indication, and what the patient actually does. The "actually does" column is where noncompliance shows up.
4. 4.Compare against the discharge list. Mark every discrepancy: on the list but not in the home, in the home but not on the list, dose different, frequency different, stopped but still taken.
5. 5.Screen the reconciled list. Duplicates (generic and brand of the same drug both present), interactions, side effects the patient describes, ineffective therapy (pain medication that does not control pain), omissions and dosage errors. The manual lists all of these as examples of potential clinically significant issues.
6. 6.Decide significance and start the clock. For each issue, decide whether it needs practitioner contact by midnight tomorrow. Record the time you identified it.
7. 7.Call, and document two-way. Record who you spoke to, what they ordered, and when the action was completed. If you reach voicemail, record the attempt and the escalation plan.
8. 8.Teach the high-risk drugs. M2010 asks whether education covered every high-risk medication on the reconciled profile. The manual says high-risk medications should be identified from an authoritative source such as the Institute for Safe Medication Practices, the American Geriatrics Society or The Joint Commission.

Collaboration is allowed. The manual permits an office clinician to help review the list, for example for duplicates or interactions, while the assessing clinician evaluates the patient, as long as findings are communicated back to the clinician who completes the OASIS.

Worked Example

An RN opens a start of care at 2:00 PM on a Monday. The discharge summary lists a new antihypertensive. On the counter is a different antihypertensive the patient took before admission and never stopped.

• 2:20 PM: Duplicate therapy identified. The RN judges it clinically significant. Deadline: 11:59 PM Tuesday.
• 2:30 PM: Call to the physician's office. Message left with staff.
• Tuesday 11:00 AM: No callback. The RN calls again from the office and reaches the office nurse, who relays the physician's instruction to continue only the new drug.
• Tuesday 3:00 PM: The RN returns to the home, removes the old bottle from the active supply with the patient's agreement, updates the medication profile and teaches the patient about the change.

M2001 is coded 1, Yes, issues found. M2003 is coded 1, Yes, because two-way communication and the prescribed action were both completed before midnight Tuesday. Had the callback come Wednesday morning, M2003 would be 0, No, regardless of the quality of care.

Why This Work Is Harder Than It Looks

The Agency for Healthcare Research and Quality's Patient Safety Network primer on medication reconciliation notes that patients often receive new medications or changes to existing ones at transitions of care, and that discharge regimens may inadvertently omit needed drugs, duplicate existing therapy or contain incorrect doses. It also notes that the evidence on which reconciliation strategies work best is mixed, and that reconciliation has proved difficult to implement well in routine practice. The home visit is often the first time anyone compares the hospital's list with what the patient actually has.

Three habits make the difference in audits:

• Recording the time of identification, not just the date. M2003 turns on hours.
• Treating aide observations as inputs. An aide who notices a new bottle or a missed dose is reporting a change in condition, which the aide supervisory visit guide lists among the elements supervision has to confirm.
• Rerunning the review at resumption of care. Every hospital stay is a new transition with a new discharge list.

Keeping the Profile Connected

A reconciled list is only useful if every later visit works from it. The HOPE assessment guide covers hospice symptom and update-visit timing, where medication changes often surface first. Nuraflow is being designed so that medication management checks the profile for allergies, duplication, interactions and timing, with an authorized clinician reconciling changes, and so that clinical documentation carries OASIS-E2 and HOPE workflows with completion routing before billing.

This article is general information, not clinical or coding advice. Use the current OASIS-E2 Guidance Manual and CMS Q&As for coding decisions, and follow your agency's clinical policies and your state's nurse practice rules.